Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Polaris Partners
Biotech
Tessa Therapeutics dissolves after raising more than $200M
Tessa Therapeutics is closing its doors after failing to woo new investors as it pursued a suite of cell therapies.
Max Bayer
Jul 6, 2023 11:55am
Tessa to use $126M series A to push CAR-Ts through clinic
Jun 9, 2022 8:57am
Satellite Bio lifts off with $110M to make implantable tissues
Apr 20, 2022 8:06am
Seismic, padded by ex-Pandion C-suite, unveils with $101M
Feb 9, 2022 7:00am
Dewpoint snags $150M for programs with Pfizer, Merck and Bayer
Feb 3, 2022 6:00am
Gerngross biotech Ankyra Therapeutics nabs $45M series B
Nov 12, 2021 8:45am
